Rishabh Singh/X
Sep 18, 2025, 07:00
Rishabh Singh on NEJM Letter: FVIII Aurora Mutation Shows Increased Activity and Reduced APC Response
Rishabh Singh, an Heme/Onc fellow at Indiana University, posted on X:
“In a letter to the editor of NEJM, authors describe a naturally occurring FVIII variant, Arg590Ser (designated FVIII Aurora), with substantially increased activity and reduced responsiveness to activated protein C as compared with wild-type FVIII.”
Title: A Naturally Occurring Gain-of-Function Mutation in Factor VIII
Authors: Joshua T. Wischmeyer, Christine H. Baird, Julian Grandvallet Contreras, Alexander Tran, Tzu Phang, Tian Liu, Marilyn J. Manco-Johnson
Read the full version here.
Find similar posts on Hemostasis Today.
-
Jun 10, 2026, 18:22Winai Porntipworawech: The $50 Life-Saving Drug Big Pharma Doesn’t Want You to See
-
Jun 10, 2026, 18:09Leonard Valentino: Innovation in Blood Disorders Being Catalyzed by Pathway to Cures
-
Jun 10, 2026, 18:00Smitirupa Mishra: Normal Hemoglobin Does Not Always Mean Normal Genes
-
Jun 10, 2026, 17:58Talat Uppal: Addressing HMB with RACGP’s Dr. Ramya Raman
-
Jun 10, 2026, 17:52Throw Back Thursday to Past Bruises Posted in the Glanzmann’s Research Foundation
-
Jun 10, 2026, 17:52Priya Prasad: In Massive Hemorrhage, Fibrinogen Is Often the First Clotting Factor to Fall
-
Jun 10, 2026, 17:51Mariam Swidan: Some Red Blood Cells Can’t Handle Pressure
-
Jun 10, 2026, 17:49Ankit Mathur: Hosting ISBT Academy Day on Rare Donor Program in India
-
Jun 10, 2026, 17:48Shadi Tabibian: When Patients Bleed but Standard Testing Is Normal